Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Magro

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Alimentary Pharmacology & Therapeutics|August 11, 2016
Proactive therapeutic drug monitoring of infliximab: a comparative study of a new point-of-care quantitative test with two established ELISA assaysJ Afonso, S Lopes, R Gonçalves, et al.
Journal of Crohn'S & Colitis|July 30, 2020
Inflammatory Bowel Disease Management During the COVID-19 Outbreak: The Ten Do's and Don'ts from the ECCO-COVID TaskforceF Magro, J-F Rahier, C Abreu, et al.
Digestive Diseases and Sciences|January 9, 2009
Inflammatory bowel disease: a patient's and caregiver's perspectiveF Magro, F Portela, P Lago, et al.
Journal of Crohn'S & Colitis|January 21, 2015
The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel diseaseC J van der Woude, S Ardizzone, M B Bengtson, et al.
Journal of Crohn'S & Colitis|April 17, 2019
Low Golimumab Trough Levels at Week 6 Are Associated With Poor Clinical, Endoscopic and Histological Outcomes in Ulcerative Colitis Patients: Pharmacokinetic and Pharmacodynamic Sub-analysis of the Evolution StudyF Magro, S Lopes, M Silva, et al.
Journal of Crohn'S & Colitis|July 23, 2013
European consensus on the histopathology of inflammatory bowel diseaseF Magro, C Langner, A Driessen, et al.
Pharmacoepidemiology and Drug Safety|March 23, 2010
Estimating the prevalence of inflammatory bowel disease in Portugal using a pharmaco-epidemiological approachL F Azevedo, F Magro, F Portela, et al.
United European Gastroenterology Journal|December 9, 2024
Serum Neutrophil Biomarkers to Predict Crohn's Disease Progression and Infliximab Treatment OutcomesD Magalhaes, M Santiago, M Patita, et al.
Journal of Crohn'S & Colitis|March 12, 2014
Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel diseaseJ F Rahier, F Magro, C Abreu, et al.
Journal of Crohn'S & Colitis|March 17, 2021
ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel DiseaseT Kucharzik, P Ellul, T Greuter, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Alimentary Pharmacology & Therapeutics|August 11, 2016
Proactive therapeutic drug monitoring of infliximab: a comparative study of a new point-of-care quantitative test with two established ELISA assaysJ Afonso, S Lopes, R Gonçalves, et al.
Journal of Crohn'S & Colitis|July 30, 2020
Inflammatory Bowel Disease Management During the COVID-19 Outbreak: The Ten Do's and Don'ts from the ECCO-COVID TaskforceF Magro, J-F Rahier, C Abreu, et al.
Digestive Diseases and Sciences|January 9, 2009
Inflammatory bowel disease: a patient's and caregiver's perspectiveF Magro, F Portela, P Lago, et al.
Journal of Crohn'S & Colitis|January 21, 2015
The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel diseaseC J van der Woude, S Ardizzone, M B Bengtson, et al.
Journal of Crohn'S & Colitis|April 17, 2019
Low Golimumab Trough Levels at Week 6 Are Associated With Poor Clinical, Endoscopic and Histological Outcomes in Ulcerative Colitis Patients: Pharmacokinetic and Pharmacodynamic Sub-analysis of the Evolution StudyF Magro, S Lopes, M Silva, et al.
Journal of Crohn'S & Colitis|July 23, 2013
European consensus on the histopathology of inflammatory bowel diseaseF Magro, C Langner, A Driessen, et al.
Pharmacoepidemiology and Drug Safety|March 23, 2010
Estimating the prevalence of inflammatory bowel disease in Portugal using a pharmaco-epidemiological approachL F Azevedo, F Magro, F Portela, et al.
United European Gastroenterology Journal|December 9, 2024
Serum Neutrophil Biomarkers to Predict Crohn's Disease Progression and Infliximab Treatment OutcomesD Magalhaes, M Santiago, M Patita, et al.
Journal of Crohn'S & Colitis|March 12, 2014
Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel diseaseJ F Rahier, F Magro, C Abreu, et al.
Journal of Crohn'S & Colitis|March 17, 2021
ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel DiseaseT Kucharzik, P Ellul, T Greuter, et al.
Pageof 5